TimesSquare Quality Mid Cap Growth ETF (TSCM)

Dealer gamma exposure on TSCM creates elevated volatility near the current strike cluster. Not adding exposure until after the backlog data clears.

On our desk, we've been tracking the rollout of TSCM since its inception in late December 2025. Co-managed by Sonu Chawla and team under a "growth with a conscience" framework, the fund targets 30 to 40 fundamentally sound mid-cap businesses. While the strategy aligns neatly with secular tailwinds like AI cybersecurity and energy sovereignty, the current AUM resting around $44M to $47M and low daily trading volumes of roughly 1.5K to 1.8K shares introduce liquidity risks that institutional allocators must carefully account for before taking large positions.

Looking at the portfolio construction reported by Morningstar and Public.com, the fund's top 10 holdings account for about 36.7% of total assets, featuring names like Snowflake, ServiceTitan, Cameco, and Vertiv Holdings. The diversification profile leans heavily into tech, industrials, and select healthcare plays like Ionis Pharmaceuticals. However, prospective investors should keep a close eye on broader macroeconomic factors—such as climbing mortgage rates, bond market volatility, and sector-specific pullbacks—which could swiftly impact mid-cap growth valuations.

When evaluating the fund's performance framework and underlying methodology, it's vital to note that TSCM focuses strictly on U.S. mid-capitalization companies exhibiting sustainable competitive advantages and stable fundamentals. For research analysts and portfolio managers evaluating how TimesSquare Capital Management executes active selection, examining their quarterly letters and thematic focuses—ranging from defense modernization to resilient infrastructure—provides a clear window into their rigorous, bottom-up screening process.